This proposal evaluates the effects of endothelium-dependent vasodilators (EDVs) on pulmonary artery (PA) endothelial cell cytosolic calcium concentration ([Ca2+]i) and nitric oxide synthesis. The importance of endothelial nitric oxide production in determining PA pressure and responsiveness to vasodilators is assessed in normal and hypertensive rats. EDRF has previously been defined by its bioassay properties. Several laboratories have proposed that EDRF bioactivity is due to the synthesis of nitric oxide from L-arginine in endothelial cells. Nitric oxide then diffuses to the adjacent vascular smooth muscle where it stimulates guanylate cyclase. It is uncertain how an EDV initiates nitric oxide synthesis; however the increase in endothelial [Ca2+]i, caused by most EDVs has been implicated as a possible signal. This """"""""nitric oxide hypothesis"""""""" requires validation in the lung. Few investigators have correlated PA vasodilation with direct measurement of nitric oxide; most have relied on EDRF bioassays or the use of nonspecific EDRF-inhibitors. HYPOTHESIS: 1 Endothelium-dependent vasodilation in the lung is not solely the result of nitric oxide synthesis. Preliminary data showing that bradykinin (BK)- and A23187-induced PA vasodilation is associated with nitric oxide synthesis whereas that caused by acetylcholine (ACH) is not. A chemiluminescence assay will be used to determine whether the magnitude and time course of nitric oxide synthesis explains the vasodilation caused by a battery of EDVs (in normal and monocrotaline PHT rats). The specificity of putative inhibitors of nitric oxide synthesis, L-monomethyl arginine (L-NMMA) and L- nitroarginine (Nitro-Arg) will be studied using a new nitric oxide assay. 2. Nitric oxide synthesis in response to EDVs is preceded by and results from a transient rise in [Ca2+]i in PA endothelial cells. Preliminary data show that BK and A23187 increase whereas ACH reduces [Ca2+]i. The spatial and temporal characteristics of changes in [Ca2+]i which occur in response to EDVs will be measured using an imaging fluorescent microscopy system. The cytosolic """"""""Ca2+ maps"""""""" created by this system will reveal the intracellular location and temporal dynamics of the various Ca2+ pools which account for the net change in [Ca2+]i caused by EDVs. It may be that change in a specific intracellular Ca2+ pool is responsible for EDV-induced nitric oxide synthesis. The importance of extracellular Ca2+ versus intracellular Ca2+ in increasing [Ca2+]i and initiating nitric oxide synthesis will be addressed. 3. Endothelial damage may alter the lung's capacity to generate nitric oxide and contribute to the development of pulmonary hypertension (PHT). The relationship of vascular structure to the ability of PA rings to dilate and synthesize nitric oxide will be studied in lungs from rats with monocrotaline-induced PHT.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29HL045735-05
Application #
2222450
Study Section
Pathology A Study Section (PTHA)
Project Start
1991-08-19
Project End
1996-07-31
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Tristani-Firouzi, M; DeMaster, E G; Quast, B J et al. (1998) Utility of a nitric oxide electrode for monitoring the administration of nitric oxide in biologic systems. J Lab Clin Med 131:281-5
Hampl, V; Tristani-Firouzi, M; Hutsell, T C et al. (1996) Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension. Cardiovasc Res 31:55-62
Hampl, V; Tristani-Firouzi, M; Nelson, D P et al. (1996) Chronic infusion of nitric oxide in experimental pulmonary hypertension: pulmonary pressure-flow analysis. Eur Respir J 9:1475-81
Tristani-Firouzi, M; Reeve, H L; Tolarova, S et al. (1996) Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel. J Clin Invest 98:1959-65
Archer, S L; Mike, D; Crow, J et al. (1996) A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD. Chest 109:750-5
Dillon, W C; Hampl, V; Shultz, P J et al. (1996) Origins of breath nitric oxide in humans. Chest 110:930-8
Archer, S L (1996) Diversity of phenotype and function of vascular smooth muscle cells. J Lab Clin Med 127:524-9
Weir, E K; Reeve, H L; Huang, J M et al. (1996) Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation 94:2216-20
Cornfield, D N; Reeve, H L; Tolarova, S et al. (1996) Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proc Natl Acad Sci U S A 93:8089-94
Archer, S L; Huang, J M; Reeve, H L et al. (1996) Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ Res 78:431-42

Showing the most recent 10 out of 29 publications